UK molecular diagnostics firm Yourgene Health said recently that it has agreed to acquire Elucigene for 9.2 million ($12.0 million) in cash and stock in a bid to bolster its presence in the noninvasive prenatal testing (NIPT) market. To fund

Recently, the Wall Street Journal reported that Swiss biopharmaceutical company Roche is acquiring US technology company Spark Theraputics, which may be announced on Monday. The acquisition will value Sparks nearly $5 billion, while the Nasd

GE has agreed to sell its BioPharma business to Danaher Corporation for $21.4 billion, adding biopharmaceutical research, development, and manufacturing instruments, equipment, and consumables to Danahers Life Science group, which includes P

NEW YORK (GenomeWeb) Illumina plans to acquire Pacific Biosciences for approximately $1.2 billion in cash, the companies said on Thursday. Under the agreement, which has been approved by both companies boards of directors, Illumina will pay

NeoGenomics recently announced a definitive agreement to acquire clinical oncology laboratory Genoptix for $125 million in cash and 1 million shares of NeoGenomics stock. Based in Carlsbad, California, Genoptix specializes on hematology and

NEW YORK (GenomeWeb) Agilent Technologies announced today that it has agreed to acquire ACEA Biosciences for $250 million in cash. Privately held ACEA, which is based in San Diego, has most recently developed a line of xCELLigence impedance-